Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kasiske BL, Snyder JJ, Gilbertson et al (2004) Cancer after kidney transplantation in the United States. Am J Transplant 4(6):905–913
Jensen P, Hansen S, Moller B et al (1999) Skin cancer in kidney and heart transplant recipients and different longterm immunosuppressive therapy regimens. J Am Acad Dermatol 40(2 Pt 1):177–186
Lindelöf B, Sigurgeirsson H, Gäbel et al (2000) Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 143(3):513–519
Ramsay HM, Fryer AA, Hawley CM et al (2002) Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 147(5):950–956
O'Donovan P, Perrett CM, Zhang X et al (2005) Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 309(5742):1871–1874
Guba M, von Breitenbuch P, Steinbauer M et al (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8(2):128–135
Yarosh DB, Boumakis S, Brown AB et al (2002) Measurement of UVB-Induced DNA damage and its consequences in models of immunosuppression. Methods 28(1):55–62
Koehl GE, Gaumann A, Zuelke C et al (2006) Development of de novo cancer in p53 knock-out mice is dependent on the type of long-term immunosuppression used. Transplantation 82(6):741–748
Kahan BD, Yakupoglu YK, Schoenberg L et al (2005) Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients. Transplantation 80(6): 749–758
Nindl I, Gottschling M, Stockfleth E (2007) Human papil-lomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis Markers 23(4):247–259
Euvrard S, Kanitakis J, Decullier E et al (2006) Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 81(8): 1093–1100
Stasko T, Brown MD, Carucci JA et al (2004) Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 30(4 Pt 2):642–650
Ackerman AB (2003) Solar keratosis is squamous cell carcinoma. Arch Dermatol 139(9):1216–1217
Braakhuis BJ, Tabor MP, Kummer JA et al (2003) A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63(8):1727–1730
Barr BB, Benton EC, McLaren K et al (1989) Papillomavirus infection and skin cancer in renal allograft recipients. Lancet 2(8656):224–225
Dragieva G, Hafner J, Dummer R et al (2004) Topical pho-todynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 77(1):115–121
Ulrich C, Bichel J, Euvrard S et al (2007) Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and effi-cacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. Br J Dermatol 157(Suppl 2):25–31
Ulrich C, Hackethal M, Ulrich M et al (2007) Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases. Br J Dermatol 156(Suppl 3):40–42
Hartevelt MM, Bavinck JN, Kootte AM et al (1990) Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 49(3):506–509
Kanitakis J, Alhaj-Ibrahim L, Euvrard S et al (2003) Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases. Arch Dermatol 139(9):1133–1137
Buell JF, Trofe J, Hanaway MJ et al (2002) Immunosuppression and Merkel cell cancer. Transplant Proc 34(5):1780–1781
Moloney FJ, Comber H, O'Lorcain P et al (2006) A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 154(3):498–504
Brown VL, Matin RN, Cerio R et al (2007) Melanomas in renal transplant recipients: the London experience, and invitation to participate in a European study. Br J Dermatol 156(1):165–167
Le Mire L, Hollowood K, Gray D et al (2006) Melanomas in renal transplant recipients. Br J Dermatol 154(3):472–477
Bastiaannet E, Homan-van der Heide JJ, Ploeg RJ et al (2007) No increase of melanoma after kidney transplantation in the northern part of The Netherlands. Melanoma Res 17(6):349–353
Penn I (1996) Malignant melanoma in organ allograft recipients. Transplantation 61(2):274–278
Penn I (1998) De novo malignances in pediatric organ transplant recipients. Pediatr Transplant 2(1):56–63
Greene MH, Young TI, Clark WH Jr (1981) Malignant melanoma in renal-transplant recipients. Lancet 1(8231):1196–1199
Dinh QQ, Chong AH (2007) Melanoma in organ transplant recipients: the old enemy finds a new battleground. Australas J Dermatol 48(4):199–207
Otley CC, Hirose R, Salasche SJ (2005) Skin cancer as a contraindication to organ transplantation. Am J Transplant 5(9):2079–2084
Penn I (1997) Transmission of cancer from organ donors. Ann Transplant 2(4):7–12
Stephens JK, Everson GT, Elliott CL et al (2000) Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation 70(1):232–236
Morris-Stiff G, Steel A, Savage P et al (2004) Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant 4(3):444–446
Serraino D, Angeletti C, Carrieri MP et al (2005) Kaposi's sarcoma in transplant and HIV-infected patients: an epide-miologic study in Italy and France. Transplantation 80(12): 1699–1704
Francès C, Mouquet C, Marcelin AG et al (2000) Outcome of kidney transplant recipients with previous human herpes-virus-8 infection. Transplantation 69(9):1776–1779
Cattaneo D, Gotti E, Perico N et al (2005) Cyclosporine formulation and Kaposi's sarcoma after renal transplantation. Transplantation 80(6):743–748
Campistol JM, Schena FP (2007) Kaposi's sarcoma in renal transplant recipients — the impact of proliferation signal inhibitors. Nephrol Dial Transplant 22(Suppl 1):i17–22
Ulrich C, Degen A, Patel MJ et al (2008) Sunscreens in organ transplant patients. Nephrol Dial Transplant 23:1805–1808
Ulrich C, Jürgensen JS, Degen A, Hackethal M, Ulrich M, Patel MJ, Eberle J, Terhorst D, Sterry W, Stockfleth E. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.HYPERLINK “javascript:AL_get(this, ‘jour’, ‘Br J Dermatol.’);”Br J Dermatol. 2009 Nov;161 Suppl 3:78–84
Penn I (2000) Cancers in renal transplant recipients. Adv Ren Replace Ther 7:147–156
Dalgleish AG, O'Byrne KJ (2002) Chronic immune activation and infl ammation in the pathogenesis of AIDS and cancer. Adv Cancer Res 84:231–276
Bonnet F, Lewden C, May T et al (2004) Malignancy-related causes of death in human immunodefi ciency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 101:317–324
Nadal SR, Calore EE, Manzione CR et al (2005) Hypertrophic herpes simplex simultating anal neoplasia in AIDS patients: report of fi ve cases. Dis Colon Rectum. 48:2289–2293
Rabkin CS, Goedert J, Biggar RJ et al (1990) Kaposi's sarcoma in three HIV-1-infected cohorts. J Acquir Immune Defic Syndr 3(Suppl1):38–43
Rasokat H, Haussermann L, Minnemann M (1989) Response of AIDS-related Kaposi's sarcoma to treatment with recombinant interferon alpha depends on the stage of underlying immunodefi ciency. J Invest Dermatol 89:444–445
Sullivan R, Dezube BJ, Koon HB (2007) Signal transduction targets in Kaposi's sarcoma. Curr Opin Oncol 18:456–462
Brockmeyer NH, Willers CP, Anders S et al (1999) Cytokine profi le of HIV-positive Kaposi's sarcoma derived cells in vitro. Eur J Med Res 4:95–100
Brockmeyer NH, Barthel B (1998) Clinical manifestations and therapies of AIDS associated tumors. Eur J Med Res 3:127–147
Krown SE, Metroka C, Wernz JC (1989) Kaposi's sarcoma in the acquired immune defi ciency syndrome: a proposal for uniform evaluation, response and staging criteria. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 7:1201–1207
Schöfer H, Brockmeyer NH (2006) Brief guidelines-Kaposi's sarcoma. JDDG 4:586–950
Maserati R et al (2000) Effects of HAART Regimen as exclusive treatment of Slow Proliferating Kaposi's Sarcoma. Int Conf AIDS 13:Abstract no TuOrB302
Sgadari C, Barillari G, Toschi E et al (2002) HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi's sarcoma. Nat Med 8:225–232
Leidner RS, Aboulafia DM (2005) Recrudescent Kaposi's sarcoma after initiation of HAART-a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS 19:635–644
Schöfer H, Ochsendorf FR, Hochscheid I, Mulbradt R (1991) Kaposi-Sarkome im Gesicht: Palliative Behandlung mit Kryochirurgie, intraläsionaler Chemotherapie, Röntgenweichstrahltherapie und Camoufl age. Hautarzt 42:492–498
Morganroth GS (2002) Topical 0.1% alitretinoin gel for classic Kaposi sarcoma. Arch Dermatol 138:542–543
Stelzer KJ, Griffin TW (1993) A randomized prospective trial of radiation therapy for AIDS-associated Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 27:1057–1061
Krown SE, Li P, Von Roenn JH et al (2002) Effi cacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study. J Interferon Cytokine Res 22:295–303
Goebel FD, Jablonowski H (1999) Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma-offi cial satellite to the 7th European Confer ence on Clinical Aspects and Treatment of HIV-infection. 23 October 1999 in Lisbon, Portugal. Eur J Res 4:507–513
Cooley T, Henry D, Tonda M et al (2007) A randomized, double-blind study of pegylated liposomal doxorubicin fort he treatment of AIDS-related Kaposi's sarcoma. Oncologist 12:114–123
Lichterfeld M, Qurishi N, Hoffmann C et al (2004) Treatment of HIV-1-associated Kaposi's sarcoma with pegylated lipo-somal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery. Infection 33:140–147
Osoba D, Northfelt DW, Budd DW, Himmelberger D (2001) Effect of treatment on health-related quality of life in acquired immunodefi ciency syndrom (AIDS)-related Kaposi's sarcoma: a randomized trial of pegylated liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine. Cancer Invest 19:573–580
Stewart S, Jablonowski H, Goebel FD et al (1998) Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal doxorubicin Study Group. J Clin Oncol 16:683–691
Lorusso D, Di Stefano A, Carone V et al (2007) Pegylated liposomal doxorubicin-related palmar-plantar erythrodyses-thesia (‘hand-foot’syndrome). Ann Oncol 18:1159–1164
Tulpule A, Groopman J, Saville MW et al (2002) Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi's sarcoma. Cancer 95:147–154
Campistol JM, Schna FP (2007) Kaposi's sarcoma in renal transplant recipients –the impact of proliferation signal inhibitors. Nephrol Dial Transplant 22 Suppl 1:i17–22
Brown HJ, Mc Bride WH, Zack JA Sun R (2005) Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus. Antivir Ther 10:745–751
Koon HB, Bubley GJ, Pantanowitz L et al (2005) Imatinib-induced regression of AIDS-related Kaposi's sarcoma. J Clin Oncol 23:982–989
Peng B, Lloyd P, Schran H (2005) Clinical pharmacokinetics of imatinib. Clin Pharmacokinet 44:879–894
Dezube BJ, Krown SE, Lee JY, Bauer KS, Aboulafia DM (2006) Randomized Phase II Trial of matrix metalloprote-iase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS malignancy consortium study. J Clin Oncol 24:1389–1394
Breen EC, Boscardin WJ, Detels R et al (2003) Non-Hodgkin's B cell lymphoma in persons with acquired immu-nodefi ciency syndrome is associated with increased serum levels of IL10, or the IL10 promoter 592 C/C genotype. Clin Immunol 10:119–129
Popovic M, Tenner-Racz K, Pelser C et al (2005) Persitence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Sci USA 102:14807–14812
Kerschmann RL, Berger TG, Weiss LM et al (1995) Cutaneous presentations of lymphoma in human immunode-fi ciency virus disease. Predominance of T cell lineage. Arch Dermatol 131:1281–1288
Macgrogan G, Vergier B, Dubus P et al (1996) CD30-positive cutaneous large cell lymphomas. A comparative study of clinicopathologic and molecular features of 16 cases. Am J Clin Pathol 105:440–450
Ezzat H, Filipenko D, Vickars L et al (2007) Improved survival in HIV-associated diffuse large B-cell lympoma with the addition of Rituximab to chemotherapy in patients receiving highly active antiretroviral therapy. HIV Clin Trials 8:132–144
Kaplan LD, Lee JY, Ambinder RF et al (2005) Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood 106:15–43
Munoz N, Bosch FX, de Sanjose S et al (2003) International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: epidemiologic classifi cation of human papil-lomavirus types associated with cervical cancer. N Engl J Med 348:518–527
Castellsague X, Diaz M, de Sanjose S et al (2006) International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Worldwide human papillo-mavirus etiology of cervical adenocarcinoma and its cofac-tors: implications for screening and prevention. J Natl Cancer Inst 98:303–315
Frisch M, Biggar RJ, Goedert JJ (2000) Human papillomavi-rus-associated cancers in patients with human immunodefi -ciency virus infection and acquired immunodefi ciency syndrome. J Natl Cancer Inst 92:1500–1510
Chin-Hong PV, Vittinghoff E, Cranston RD (2005) Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst 97:896–905
Kreuter A, Brockmeyer NH, Hochdorfer B et al (2005) Clinical spectrum and virologic characteristics of anal intra-epithelial neoplasia in HIV infection. J Am Acad Dermatol 52:603–608
Palefsky JM, Holly EA, Efirdc JT et al (2005) Anal intraepi-thelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 19:1407–1414
Cusini M, Salmaso F. Zerboni R et al (2004) 5% imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy. Int J STD AIDS 15:17–20
Abbasakoor F, Boulos PB (2005) Anal intraepithelial neo-plasia. Br J Surg 92:277–290
Wieland U, Brockmeyer NH, Weisenborn SJ (2006) Imiquimod treatment of anal Intraepithelial neoplasia in HIV positive men. Arch Dermatol 142:1430–44
Burgi A, Brodine S, Wegner S et al (2005) Incidence and risk factors for the occurrence of non-AIDS-defi ning cancers among human immunodefi ciency virus-infected individuals. Cancer 104:1505–1511
Oram Y, Orengo I, Griego RD et al (1995) Histologic patterns of basal cell carcinoma based upon patient imunosta-tus. Dermatol Surg 21:611–614
Flegg PJ (1990) Potential risks of ultraviolet radiation in HIV infection. In J STD AIDS 1:46–48
Lobo DV, Chu P, Grekin RC, Berger TG (1992) Nonmelanoma skin cancers and infection with the human immunodefi -ciency virus. Arch Dermatol 128:623–627
Wilkens K, Turner R, Dolev JC et al (2006) Cutaneous malignancy and human immunodefi ciency virus disease. J Am Acad Dermatol 54:189–206
Nguyen P, Vin-Christian K, Ming ME, Berger T (2002) Aggressive squamous cell carcinomas in persons infected with the human immunodefi ciency virus. Arch Dermatol 138:758–763
An KP, Ratner D (2001) Merkel cell carcinoma in the setting of HIV infection. J Am Acad Dermatol 45:309–312
Calza L, Beltrami C, Manfredi R et al (2002) Merkel cell carcinoma in a human immunodefi ciency virus-infected patient. Br J Dermatol 146:895–898
Colebunders R, Bottieau E, Van den Brande J et al (2004) Merkel cell carcinoma and multiple basal cell carcinoma in an African albino woman with HIV infection. HIV Medicine 5:452–453
Engels EA, Frisch M, Goerdert JJ et al (2002) Merkel cell carcinoma and HIV infection. Lancet 359:497–498
Solomon RK, Lundeen SJ, Hamlar DD, Pambuccian SE (2001) Fine needle aspiration diagnosis of unusual cutaneous neoplasms of the scalp in HIV-infected patients. Diagn Cytopathol 24:186–192
Pantanowitz L, Schlecht HP, Dezube BJ (2006) The growing problem of non-AIDS-defi ning malignancies in HIV. Curr Opin Oncol 18:469–478
Calista D (2001) Five cases of melanoma in HIV positive patients. Eur J Dermatol 11:446–944
Rodrigues LK, Klencke BJ, Vin-Christian K et al (2002) Altered clinical course of malignant melanoma in HIVpositive patients. Arch Dermatol 138:765–770
Munoz N, Bosch FX, de Sanjose S et al (2003) International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: epidemiologic classification of human papil-lomavirus types associated with cervical cancer. N Engl J Med 348:518 –527
Garland SM, Hernandez-Avila M, Weeher CM et al (2007) Quadrivalent vaccine against human papilloma virus to prevent anogenital disease. N Engl J Med 356:1928 –1943
Markowitzh LE, Dunne EF, Saraiya M et al (2007) Quadrivalent human papilloma virus vaccine. MMWR 56:1 –24
Harper DM, Franco EL, Wheeler C et al (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364:1757 –1765
Harper DM, Franco EL, Wheeler C et al (2006) Sustained efficacy up to 4,5 years of bivalent L1 virus-like particle vaccine against human papillomavirus types 16 an 18: follow-up from a randomised control trial. Lancet 367:1247 –1255
Morath C, Mueller M, Goldschmidt H et al (2004) Malignancy in renal transplantation. J Am Soc Nephrol 15:1582 –1588
Abbasakoor F, Boulos PB (2005) Anal intraepithelial neo-plasia. Br J Surg 92:277 –290
Goldstone SE, Kawalek AZ, Huyett JW (2005) Infrared coagulator: a useful tool for treating anal squamous intraepi-thelial lesions. Dis Colon Rectum 48:1042 –1054
Berry JM, Palefsky JM, Welton ML (2004) Anal cancer and its precursors in HIV-positive patients: perspectives and management. Surg Oncol Clin N Am 13:355 –373
UKCCCR Anal Cancer Trial Working Party (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin. Lancet 348:1049 –1054
Kreuter A, Reimann G, Esser S et al (2003) Screening and therapy of anal intraepithelial neoplasia (AIN) and anal carcinoma in patients with HIV-infection. Dtsch Med Wochenschr 128:1957 –1962
Palefsky JM, Holly EA, Hogeboom CJ et al (1998) Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIVpositive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 17:314 –319
Micali G, Nasca MR, Innocenzi D, Schwartz RA (2006) Penile cancer. J Am Acad Dermatol 54:369 –391
Van der Avoort IA, Shirango H, Hoevenaars BM et al (2006) Vulvar squamous cell carcinoma is a multifactorial disese following two separate and independent pathways. Int J Gynecol Pathol 25:22 –92
Pecorelli S (1998) FIGO annual report on the result of treatment in gynaecological cancer. J Epidemiol Biostat 3:1 –168
Krathen RA, Donelly HB (2007) Mohs micrographic surgery for squamous cell carcinoma arising within lichen scle-rosus. Dermatol Surg 33:990 –993
Rasponellinin MR, Asirelli G, Taddei GL (2007) The role of angiogenesis and COX-2 expression in the evolution of vul-var lichen sclerosus to squamous cell carcinoma of the vulva. Gynecol Oncol 106:567 –571
Fischer G, Bradford J (2007) Topical immunosuppressants, genital lichen sclerosus and the risk of squamous cell carcinoma: a case report. J Reprod Med 52:329 –331
Lewis FM, Neill SM (2007) Safety of calcineurin inhibitors in the management of lichen sclerosis. Br J Dermatol 156:1389 –1390
El Shabrawi-Caelen L, Soyer HP, Schaeppi H et al (2004) Genital lentigines and melanocytic nevi with superimposed lichen sclerosus: a diagnostic challenge. J Am Acad Dermatol 50:690 –694
Patrick RJ, Fenske NA, Messina JL (2007) Primary mucosal melanoma. J Am Acad Dermatol 56:828 –834
Rohwedder A, Slominsi A, Wolff M et al (2007) Epider-modysplasia verruciformis and cutaneous human papilloma-virus DNA, but not genital human papillomavirus DNAs, are frequently detected in vulvar and vaginal melanoma. Am J Dermatopathol 29:13 –17
Dhar KK, Das N, Brinkman DA et al (2007) Utility of sentinel node biopsy in vulvar and vaginal melanoma: report of two cases and review of the literature. Int J Gynecol Cancer 17:720 –723
Jahnke A, Makovitzky J, Vriese V (2005) Primary melanoma of the female genital system: a report of 10 cases and review of the literature. Anticancer Res 25:1567 –1574
Sugiyama VE, Chan JK, Shin JY et al (2007) Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol 110:296 –301
Manavi K, Kemmett D (2005) A case of penile superficial basal cell carcinoma involving the inner surface of foreskin. Int J STD AIDS 16:766 –767
Pisani C, Poggiali S, De Padova L et al (2006) Basal cell carcinoma of the vulva. J Eur Acad Dermatol Venereol 20:446 –448
Wang SO, Goldberg LH (2007) Multiple polypoid basal cell carcinomas on the perineum of a patient with basal cell nevus syndrome. J Am Acad Dermatol 57(Suppl 2):36 –37
Siesling S, Elferink MA, van Dijck JA et al (2007) Epidemiology and treatment of extramammary Paget disease in the Nehterlands. Eur J Surg Oncol 33:951 –955
Yang WJ, Kim DS, Im YJ et al (2005) Extramammary Paget 's disease of penis and scrotum. Urology 65:972
Virich G, Gudi V, Canal A (2008) Extramammary Paget 's disease-occupational exposure to used engine oil and a new skin grafting technique. J Plast Reconstr Aesthet Surg 61:1528 –1529
Tsujino Y, Kusatake K, Kneko S et al (2007) Fusion of singlephoton emission computed tomography and computed tomography images of sentinel lymph nodes in extramam-mary Paget 's disease of the scrotum. J Dermatol 34:712 –715
Vereecken P, Awada A, Ghanem G et al (2007) A therapeutic approach to perianal extramammary Paget 's disease: topical imiquimod can be useful to prevent of defer surgery. Med Sci Monit 13:CS75 –7
Raspagliesi F, Fontanelli R, Rossi G et al (2006) Photody-namic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget 's disease of the vulva: a pilot study. Gynecol Oncol 103:581 –586
Ye JN, Rhew DC, Yip F, Edelstein L (2006) Extramammary Paget 's diseae resistant to surgery and imiquimod monother-apy but responsive to imiquimod combination topical chemotherapy with 5-fluorouracil and retinoic aid: a case report. Cutis 77:245 –250
Zhu Y, Ye DW, Chen ZW et al (2007) Frozen section-guided wide local excision in the treatment of penoscrotal extra-mammary Paget 's disease. BJU Int 100:1282 –1287
Oguchi S, Kaneko M, Uhara H, Saida T (2002) Docetaxil induced durable response in advanced extramammary Paget 's disease: a case report. J Dermatol 29:33 –37
Mochitomi Y, Sakamoto R, Gushi A et al (2005) Extramam-mary Paget 's disease/carcinoma successfully treated with a combination chemotherapy: report of two cases. J Dermatol 32:632 –637
Klimis T, Margaritopoulou A, Panopulos J, Kokotas N (2007) Primary classic penile Kaposi 's sarcoma in an elderly HIV-negative patient: report of a case and review of the literature. J BUON 12:117 –119
Micali G, Nasca MR, De Pasquale R, Innocenzi D (2003) Primary classic Kaposi 's sarcoma of the penis: report of a case and review. J Eur Acad Dermatol Venereol 17:320 –323
Morelli L, Pusiol T, Piscioli F et al (2003) Herpesvirus 8-associated penile Kaposi 's sarcoma in an HIV-negative patient: first report of a solitary lesion. Am J Dermatopathol 25:28 –31
Katongole-Mbidde E, Banura C, Nakakeeto M (1989) Diagnostic implicatons of genital Kaposi 's sarcoma. East Afr Med J 66:499 –502
Macasaet MA, Duerr A, Thelmo W et al (1995) Kaposi sarcoma presenting as a vulvar mass. Obstet Gynecol 86:695 –697
Le Bourgeois JP, Frikha H, Pedbois P et al (1994) Radiotherapy in the management of epidemic Kaposi 's sarcoma of the oral cavity, the eyelid and the genitals. Radiother Oncol 30:263 –266
Vapnek JM, Quivey JM, Carrol PR (1991) Acquired immu-nodeficiency syndrome-related Kaposi 's sarcoma of the male genitalia: management with radiation therapy. J Urol 146:333 –336
Swierzewski SJ III, Wan J, Boffini A, Faerber GJ (1993) The management of meatal obstruction due to Kaposi 's sarcoma of the glans penis. J Urol 150:193 –195
Nucci MR, Fletcher CD (2000) Vulvovaginal soft tissue tumours: update and review. Histopathology 36:97 –108
Tsuji T, Yoshinaga M, Inomoto Y et al (2007) Aggressive angiomyxoma of the vulva with a sole t(5:8)(p15;q22) chromosome change. Int J Gynecol Pathol 26:494 –496
Omori M, Toyoda H, Hirai T et al (2006) Angiomyofibro-blastoma of the vulva: a large pedunculated mass formation. Acta Med Okayama 60:237 –242
Nadal SR, Calore EE, Manzione CR et al (2005) Hypertrophic herpes simplex simulating anal neoplasia in AIDS patients: report of five cases. Dis Colon Rectum 48:2289 –2293
Garman M, Metry D (2006) Vulvar synringomas in a 9-year-old child with review of the literature. Pediatr Dermatol 23:369 –372
Kontogianni-Katsaros K, Kairi-Vassilatoy E, Grapsa D et al (2006) Angiokeratoma of the vulva: a rare benign vascular tumor mimicking malignancy –case report. Eur J Gynaecol Oncol 27:632 –633
Gupta R, Singh S, Nigam S, Khurana N (2006) Benign vascular tumors of female genital tract. Int J Gynecol Cancer 16:1195 –1200
Kondi-Pafiti A, Kair-Vassilatou E, Spanidou-Carvouni H et al (2003) Vascular tumors o the female genital tract: a clinicopathological study of nine cases. Eur J Gynaecol Oncol 24:48 –50
Micheletti AM, Silva AC, Nascimento AG et al (2005) Cellular angiofibroma of the vulva: case report with clinico-pathological and immunohistochemistry study. Sao Paulo Med J 123:250 –252
Misago N, Narisawa Y (2004) Polypoid basal cell carcinoma on the perianal region: a case report and review of the literature. J Dermatol 31:51 –55
Wieland U, Brockmeyer NH, Weissenborn SJ et al (2006) Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men. Arch Dermatol 142:1438 –1444
Silverberg NB (2001) Update on malignant melanoma in children. Cutis 67:393–396
Strouse JJ, Fears TR, Tucker MA et al (2005) Pediatric melanoma: risk factor and survival analysis of the Surveillance, Epidemiology and End Results Database. J Clin Oncol 23:4735–4741
Tate PS, Ronan SG, Feucht KA et al (1993) Melanoma in childhood and adolescence: clinical and pathological features of 48 cases. J Pediatr Surg 28:217–222
Strojan P, Lamovec J (2000) Prepubertal malignant melanoma: report of three cases. Pediatr Hematol Oncol 17:163–169
Holly EA, Kelly JW, Shpall SN et al (1987) Number of mel-anocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 17:459–468
Skender-Kalnenas TM, English DR, Heenan PJ (1995) Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 33:1000–1007
Bauer J, Garbe C (2003) Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data. Pigment Cell Res 16:297–306
Whiteman DC, Whiteman CA, Green AC (2001) Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 12:69–82
Oliveria SA, Saraiya M, Geller AC et al (2006) Sun exposure and risk of melanoma. Arch Dis Child 91:131–138
Huynh PM, Grant-Kels JM, Grin CM (2005) Childhood melanoma: update and treatment. Int J Dermatol 44:715–723
Schmid-Wendtner MH, Berking C, Baumert J et al (2002) Cutaneous melanoma in childhood and adolescence: an analysis of 36 patients. J Am Acad Dermatol 46:874–879
Soares de Sá BC, Rezze GG, Scramim AP et al (2004) Cutaneous melanoma in childhood and adolescence: retrospective study of 32 patients. Melanoma Research 14:487–492
Davidoff AM, Cirrincione C, Seigler HF (1994) Malignant melanoma in children. Ann Surg Oncol 1:278–282
Swerdlow AJ, English JS, Qiao Z (1995) The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol 32:595–599
Marghoob AA, Dusza S, Oliveria S et al (2004) Number of satellite nevi as a correlate for neurocutaneous melanocyto-sis in patients with large congenital melanocytic nevi. Arch Dermatol 140:171–175
Arons MS, Hurwitz S (1983) Congenital nevocellular nevus: a review of the treatment controversy and a report of 46 cases. Plast Reconstr Surg 72:355–365
Spatz A, Ruiter D, Hardmeier T et al (1996) Melanoma in childhood: an EORTC-MCG multicenter study on the clin-ico-pathological aspects. Int J Cancer 68:317–324
Novakovic B, Clark WH Jr, Fears TR et al (1995) Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families. J Am Acad Dermatol 33:631–636
Watt AJ, Kotsis SV, Chung KC (2004) Risk of melanoma arising in large congenital melanocytic nevi: a systematic review. Plast Reconstr Surg 113:1968–1974
Bütter A, Hui T, Chapdelaine J et al (2005) Melanoma in children and the use of sentinel lymph node biopsy. J Pediatr Surg 40:797–800
Schäfer-Hesterberg G, Schoengen A, Sterry W et al (2007) The use of ultrasound to early identify, diagnose and localize metastases in melanoma patients. Expert Rev Anticancer Ther 7(12):1707–1716
Navid F, Furman WL, Fleming M et al (2005) The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma. Cancer 103:780–787
Spitz S (1948) Melanomas of childhood. Am J Pathol 24:591–609
Barnhill RL, Barnhill MA, Berwick M et al (1991) The his-tologic spectrum of pigmented spindle cell nevus: a review of 120 cases with emphasis on atypical variants. Hum Pathol 22:52–58
Massi G (2007) Melanocytic nevi simulant of melanoma with medicolegal relevance. Virchows Arch 451:623–647
Ferrara G, Argenziano G, Soyer HP et al (2005) The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol 141:1381–1387
Spatz A, Calonje E, Handfield-Jones S et al (1999) Spitz tumors in children: a grading system for risk stratification. Arch Dermatol 135:282–285
King MS, Porchia SJ, Hiatt KM (2007) Differentiating spit-zoid melanomas from Spitz nevi through CD99 expression. J Cutan Pathol 34:576–580
Kapur P, Selim MA, Roy LC et al (2005) Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohis-tochemical analysis. Mod Pathol 18:197–204
Barnhill RL (2006) The Spitzoid lesion: rethinking Spitz tumors, atypical variants, ‘Spitzoid melanoma’ and risk assessment. Mod Pathol 19 Suppl 2:S21–S33
Zangari A, Bernardini ML, Tallarico R et al (2007) Indications for the excision of nevi and melanoma diagnosed in a pediatric surgical unit. J Pediatr Surg 42:1412–1416
Casso EM, Grin-Jorgensen CM, Grant-Kels JM (1992) Spitz nevi. J Am Acad Dermatol 27:901–913
Shapiro PE (1993) Spitz nevi. J Am Acad Dermatol 29:667–668
LeBoit PE (2002) “Safe” Spitz and its alternatives. Pediatr Dermatol 19:163–165
Setterfield J, Sciot R, Debiec-Rychter M et al (2002) Primary cutaneous epidermotropic alveolar rhabdomyosarcoma with t(2;13) in an elderly women. Am J Surg Pathol 26:938–944
Lobe TE, Wiener ES, Hays DM et al (1994) Neonatal rhab-domyosarcoma: the IRS experience. J Pediatr Surg 29:1167–1170
Toro JR, Travis LB, Wu HJ et al (2006) Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: an analysis of 26,758 cases. Int J Cancer 119:2922–2930
Brecher AR, Reyes-Mugica M, Kamino H et al (2003) Congenital primary cutaneous rhabdomyosarcoma in a neo-nate. Pediatr Dermatol 20:335–338
Taylor RW (1890) Sarcomatous tumors resembling in some respects keloids. Arch Dermatol 8:384–387
Hoffmann E (1925) Über das knollentreibende Fibrosarkom der Haut (Dermatofibrosarcoma protuberans). Dermat Zeitschr 43:1–28
Craver RD, Correa H, Kao YS et al (1995) Aggressive giant cell fibroblastoma with a balanced 17;22 translocation. Cancer Genet Cytogenet 80:20–22
Minoletti F, Miozzo M, Pedeutour F et al (1995) Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protu-berans. Genes Chromosomes Cancer 13:62–65
Pedeutour F, Simon MP, Minoletti F et al (1996) Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. Cytogenet Cell Genet 72:171–174
Jha P, Moosavi C, Fanburg-Smith JC (2007) Giant cell fibro-blastoma: an update and addition of 86 new cases from the armed forces institute of pathology, in honor of Dr. Franz Enzinger. Ann Diagn Pathol 11:81–88
Dupree WB, Langloss JM, Weiss SW (1985) Pigmented der-matofibrosarcoma protuberans (Bednar tumor). A pathologic, ultrastructural, and immunohistochemical study. Am J Surg Pathol 9:630–639
McPeak CJ,Cruz T,Nicastri AD (1967) Dermatofibrosarcoma protuberans: an analysis of 86 cases — five with metastasis Ann Surg 166:803–816
von Stebut E, Bräuninger W (2007) Congenital dermatofib-rosarcoma protuberans: 30 years of follow-up. JDDG 5:223–225
NG A, Nishikawa H, Lander A et al (2005) Chemosensitivity in pediatric dermatofibrosarcoma protuberans. J Pediatr Hematol Oncol 27:100–102
Rubin BP, Schuetze SM, Eary JF et al (2002) Molecular targeting of platelet-derived growth factor B by imatinib mesy-late in a patient with metastatic dermatofibrosarcoma protuberans. J Clin Oncol 20:3586–3591
Price VE, Fletcher JA, Zielenska M et al (2004) Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuber-ans. Pediatr Blood Cancer 44:511–515
Bazex A, Griffiths A (1980) Acrokeratosis paraneoplastica. A new cutaneous marker of malignancy. Br J Dermatol 102:304
Bolognia JL, Brewer YP, Cooper DL (1991) Bazex 's syndrome. Analytic review. Medicine 70:269 –280
Richard M, Giroux JM (1987) Acrokeratosis paraneoplastic (Bazex syndrome). J Am Acad Dermatol 16:178 –183
Lemont H, Haas R (1994) Subungual pigmented Bowen 's disease in a nineteen-year-old black female. J Am Podiatr Med Assoc 84:39 –40
Saijo S, Kato T, Tagami H (1990) Pigmented nail streak associated with Bowen 's disease of the nail matrix. Dermatologica 181:156 –158
Henry M, Renaut JJ, Baran R et al (2003) Bande pigmentée unguéale acquise, révélatrice d'un carcinome épidermoïde du lit de l'ongle. Nouv Dermatol 22(Suppl 2):19 –20
Baran R, Simon C (1988) Longitudinal melanonychia: a symptom of Bowen 's disease. J Am Acad Dermatol 18: 1359 –1360
Baran R, Eichmann A (1993) Longitudinal melanonychia associated with Bowen disease. Dermatology 186:159 –160
Sass U, André J, Stene JJ et al (1998) Longitudinal mel-anonychia revealing an intraepidermal carcinoma of the nail apparatus: detection of integrated HPV-16 DNA. J Am Acad Dermatol 39:490 –493
Haneke E (1991) Epidermoid carcinoma (Bowen 's disease) of the simulating acquired ungual fibrokeratoma. Skin Cancer 6:217 –221
Baran R, Perrin C (1987) Pseudo-fibrokeratoma of the nail apparatus: a new clue for Bowen disease. Arch Dermatol 74:449 –450
Dominguez-Cherit J, Garcia C, Vega-Memije ME, Arenas R (2003) Pseudo-fibrokeratoma: an unusual presentation of subungual squamous cell carcinoma in a young girl. Dermatol Surg 29:788 –789
Sau P, McMarlin SL, Sperling LC et al (1994) Bowen 's disease of the nail bed and periungual area. A clinicopathologic analysis of seven cases. Arch Dermatol 130:204 –209
Saxena A, Kasper DA, Campanelli CD et al (2006) Pigmented Bowen 's disease clinically mimicking melanoma of the nail. Dermatol Surg 32:152 –155
Baran R, Perrin C (2000) Longitudinal erythronychia with distal subungual keratosis: onychopapilloma of the nail bed and Bowen 's disease. Br J Dermatol 143:132 –135
Dalle S, Depape L, Phan A et al (2007) Squamous cell carcinoma of the nail apparatus: clinicopathological study of 35 cases. Br J Dermatol 156:871 –874
Reuter G, Keller F, Samama et al (2005) Maladie de Bowen à type d'Erythronychie longitudinale. Aspect dermoscopique et étude virologique. Ann Dermatol Venereol 132:596
Baran R, Gormley D (1987) Polydactylous Bowen 's disease of the nail. J Am Acad Dermatol 17:201 –204
Goodman G, Mason G, O'Brien T (1995) Polydactylous Bowen 's disease of the nail bed. Aust J Dermatol 36: 164 –165
Koch A, Schönlebe J, Haroske G et al (2003) Polydactylous Bowen 's disease. JEADV 17:213 –215
Baran R, Tosti A, De Berker D (2003) Periungual keratoacan-thoma preceded by a wart and followed by a verrucous carcinoma at the same site. Acta Derm Venereol 83:232 –233
High WA, Tyring SK, Taylor RS (2003) Rapidly enlarging growth of the proximal nail fold. Dermatol Surg 29:984 –986
Baran R, Perrin C (2002) Bowen 's disease clinically simulating an onychomatricoma. J Am Acad Dermatol 47:947 –949
Chang SE, Choi JH, Sung KJ et al (1999) Metastatic squamous cell carcinoma of the nail bed: a presenting sign of lung cancer (letter). Br J Dermatol 141(5):939 –940
Vanhooteghem O, Dumont M, André J et al (1999) Métastases sous-unguéales bilatérales de carcinome spino-cellulaire pulmonaire: un piège diagnostique! Rev Med Liege. 54(8):653 –654
Forslund O, Nordin P, Andersson K et al (1997) DANN analysis indicates patient-specific human papillomavirus type 16 strains in Bowen 's disease of fingers and in archival samples from genital dysplasia. Br J Dermatol 136: 678 –682
Tosti A, Morelli K, Fanti PA et al (1993) Carcinoma cunicu-latum of the nail apparatus: report of three cases. Dermatol 186:217 –221
Van Geertruyden JP, Olemans C, Laporte M et al (1998) Verrucous carcinoma of the nail bed. Foot Ankle Int 19:327 –328
Spencer JM (2002) Malignant tumors of the nail unit. Dermatol Ther 15:126 –130
Laffitte E, Saurat JH (2003) Maladie de Bowen unguéale récidivante: traitement par imiquimod topique (Aldara). Ann Dermatol Venereol 130:211 –213
Tan B, Sinclair R, Foley P (2004) Photodynamic therapy for subungual Bowen 's disease. Australas J Dermatol 45: 172 –174
Wong TW, Sheu HM, Lee YY et al (2001) Photodynamic therapy for Bowen 's disease (squamous cell carcinoma in situ) of the digit. Dermatol Surg 27:452 –456
Sheen YS, Sheen MC, Sheu HM (2003) Squamous cell carcinoma of the big toe successfully treated by intra-arterial infusion with methotrexate. Dermatol Surg 29:982 –983
Albert LI, Zack FG, Werthamer S (1972) Subungual basal cell epithelioma. Arch Dermatol 106:599
Mikhail GR (1985) Subungual basal cell carcinoma. J Dermatol Surg Oncol 11:1222–1223
Brazie RA, Patel A, Nouri K (2006) Basal cell carcinoma of the nail unit treated with Mohs micrographic surgery: superfi-cial multicentric BCC with jagged borders — an histopathologi-cal hallmark for nail unit BCC. J Drugs Dermatol 5:660–663
Martinelli PT, Cohen PR, Schulze KE et al (2006) Periungual basal cell carcinoma: case report and literature review. Dermatol Surg 32:320–323
Rudolph RI (1987) Subungual basal cell carcinoma presenting as longitudinal melanonychia. J Am Acad Dermatol 16:229–233
Okuyama R, Watanabe H, Alba S et al (2006) Subungual basal cell carcinoma in an elderly Japanese woman. Acta Derm Venereol 86:261
Hoffman S (1973) Basal cell carcinoma of the nail bed. Arch Dermatol 108:828
Baran R, Tosti A (1994) Metastatic bronchogenic carcinoma to the terminal phalanx of the toe. Report of 2 cases and review of the literature. J Am Acad Dermatol 31:259–263
Cohen P (2001) Metastatic tumors to the nail unit: subungual metastases. Dermatol Surg 27:280–293
Gallagher B, Yousef G, Bishop L (2006) Subungual metastasis from a rectal primary: case report and review of the literature. Dermatol Surg 32:592–595
Retsas S, Samman PD (1983) Pigment streaks in the nail plate due to secondary malignant melanoma. Br J Dermatol 108:367–370
Spencer JM (2002) Malignant tumors of the nail unit. Dermatol Ther 15:126–130
Metzger S, Ellwanger U, Stroebel W et al (1998) Extent and consequences of physician delay in the diagnosis of acral melanoma. Melanoma Res 8:181–186
Kopf AW, Bart RS (1977) Malignant melanoma. J Surg Oncol 3:49–53
Levit EK, Kagen MH, Scher RK (2000) The ABC rule for clinical detection of subungual melanoma. J Am Acad Dermatol 42:269–274
Kato T, Suetake T, Sugiyama Y et al (1996) Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol 134:383–387
Thai KE, Young R, Sinclair RD (2001) Nail apparatus melanoma. Australas J Dermatol 42(2):71–81
Clark WH, Bernardino EA, Reed RJ et al (1979) Acral len-tiginous melanoma. In: Clark WH, Geodman LI, Mastrangers (eds) Human malignant melanoma. Grune & Stratton, New York, pp 109–124
Milton GH, Show HM, Mc Carthy WH (1985) Subungual malignant melanoma. A disease entity separate from other forms of cutaneous melanoma. Australas J Dermatol 26:61–64
Miura S, Jimbow K (1985) Clinical characteristics of subun-gual melanoma in Japan. Case report and questionnaire survey of 108 cases. J Dermatol 12:393–402
Baran R, Kechijian P (1989) Longitudinal melanonychia. Diagnosis and management. J Am Acad Dermatol 21:1165–1175
Haneke E, Baran R (2001) Longitudinal melanonychia. Dermatol Surg 27(6):580–584
Nogaret JM, André J, Parent D et al (1986) Le mélanome des extrémités, diagnostic méconnu et traitement délicat. Revue des 20 observations. Acta Chir Belg 86:238–244
Retsas S, Samman PD (1983) Pigment streaks in the nail plate due to secondary malignant melanoma. Br J Dermatol 108:367–370
Ronger S, Touzet S, Ligeton C et al (2002) Dermoscopic examination of nail pigmentation. Arch Dermatol 138:1327–1333
Kopf AW (1981) Hutchinson 's sign of subungual malignant melanoma. Am J Dermatopathol 3:201–202
Baran R, Kechijian P (1996) Hutchinson 's sign: a reappraisal. J Am Acad Dermatol 34:87–90
Kawabata Y, Ohara K, Hino H et al (2001) Two kinds of Hutchinson 's sign: benign and malignant. J Am Acad Dermatol 44(2):305–307
André J, Lateur N (2006) Pigmented nail disorders. Dermatol Clin 24:329–340
Banfield CC, Redburn JC, Dawber RPR (1998) The incidence and prognosis of nail apparatus melanoma. A retrospective study of 105 patients in four English regions. Br J Dermatol 139:276–279
Achten G (1982) What 's new about normal and pathologic nail. Abstracts in XVI International Congress of Dermatology, Tokyo, 17–18
Perrin C, Baran R (1994) Longitudinal melanonychia caused byTrichophyton rubrum. J Am Acad Dermatol 31:311–316
Jellinek NJ (2005) Primary malignant tumors of the nail unit. Adv Dermatol 21:33–64
Banfield CC, Dawber RPR, Walker NP et al (1999) Mohs micrographic surgery for the treatment of in situ nail apparatus melanoma: a case report. J Am Acad Dermatol 40:98–99
Gloster HM and Neal K (2006) Skin Cancer in Skin of Color, J Am Acad Dermatol 55:761–764
Halder RM, Bang KM (1988) Skin cancer in blacks in the United States. Dermatol Clin 6:397–405
Halder RM, Bridgeman-Shah S (1995) Skin cancer in African Americans. Cancer 75:667–673
Mora RG, Perniciaro C (1981) Cancer of the skin in blacks: I. a review of 163 black patients with cutaneous squamous cell carcinoma. J Am Acad Dermatol 5:535–543
Fleming ID, Barnawell JR, Burlison PE, Runkin JS (1975) Skin cancer in black patients. Cancer 35:600–605
Crowley NJ, Dodge R, Vollmer RT, Seigler HF (1991) Malignant melanoma in African Americans: a trend towards improved survival. Arch Surg 126:1359–6135
Mora RG, Burris R (1981) Cancer of the skin in African Americans: a review of 128 patients with basal cell carcinoma. Cancer 47:1436–1438
Koh D, Wang H, Lee J, Chia KS, Lee HP, Goh CL (2003) Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry Data 1968e 1997. Br J Dermatol 148:1161–1166
Budhraja SN, Pillai VC, Periyanayagam WJ, Kaushik SP, Bedi BM (1972) Malignant neoplasms of the skin in Pondicherry (a study of 102 cases). Indian J Cancer 9:284–295
Chakravorty RC, Dutta-Choudhuri R (1968) Malignant neoplasms of the skin in eastern India. Indian J Cancer 5:133–414
Paymaster JC, Talwalkar G V, Gangadharan D (1971) Carcinomas and malignant melanomas of the skin in western India. J Royal Coll Surg 16:166–173
Shahi UP, Fernandes P, Shukla NK, Chandler S, Eoin B, Rath GK (1989) Electron beam irradiation in treatment of skin carcinoma. Indian J Cancer 26:41–45
Dhir A, Orengo I, Bruce S, Kolbusz RV, Alford E, Goldberg L (1995) Basal cell carcinoma on the scalp of an Indian patient. Dermatol Surg 21:247–250
Scotto J, Fears TR, Fraumeni JF Jr (1981) Incidence of nonmelanoma skin cancer in the United States. US Government Printing Office, Washington, DC. National Cancer Institute, DHHS Report No. NIH 82–2433
Gloster HM, Brodland DG (1996) The epidemiology of skin cancer. Dermatol Surg 22:217–226
Armstrong BK, Kricker A (1995) Skin cancer. Dermatol Clin 13:583–954
Hall HI, Miller DR, Rogers JD, Bevers B (1999) Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 40:35–42
Ichihashi M, Naruse K, Harada S, Nagano T, Nakamura T, Suzuki T et al (1995) Trends in nonmelanoma skin cancer in Japan. Recent Results Cancer Res 139:263–723
Naruse K, Ueda M, Nagano T, Suzuki T (1997) Prevalence of actinic keratoses in Japan. J Dermatol Sci 15:183–187
Harris RB, Griffith K, Moon TE (2001) Trends in incidence of nonmelanoma skin cancers in southeastern Arizona, 1985–1996. J Am Acad Dermatol 45:528–536
Weinstock MA (1993) Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Arch Dermatol 129:1286–1290
Ries LA, Kosary CL, Hankey BF, Miller BA (eds) (1997) SEER cancer statistics review, 1973e1994 (NIH Publication no. 97–2789). National Cancer Institute, Bethesda (MD)
US Census Bureau Population Division (2000) Projections of the resident population by race, Hispanic origin, and nativity: middle series, 1999–2100. US Census Bureau, Washington, DC
Montagna W, Prota G, Kenney JA Jr (1993) Black skin structure and function. Academic Press, London, pp 55–60
Anderson KE (1979) Black and white human skin differences. J Am Acad Dermatol 1:276–282
Montagna W (1991) The architecture of black and white skin. J Am Acad Dermatol 24:29–37
Kollias N, Sayre RM, Zeise L, Chedekel MR (1991) Protection by melanin. J Photochem Photobiol 9:135–160
Foster HM, Webb SJ (1988) Skin cancer in the North Solomons. Aust N Z J Surg. 58(5):397–401
Madronich S, de Gruijl FR (1993) Skin cancer and UV radiation. Nature 366:23
Armstrong BK, Kricker A (2001) The epidemiology of UV induced skin cancer. J Photochem Photobiol B 63:8–18
Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DS (1996) Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol Symp Proc 1:136–142
Scotto J, Fears TR, Fraumeni JF (1983) Incidence of non-melanoma skin cancer in the United States. US Government Printing Office, Washington, DC, NIH Report No. 83–2433
Weinstock MA (1993) Epidemiology of melanoma. Cancer Treat Res 65:29–56
Dennis LK, White E, Lee JA (1994) Recent cohort trends in malignant melanoma by anatomic site in the United States. Cancer Causes Control 5:440–448
Chuang TY, Reizner GT, Elpern DJ, Stone JL, Farmer ER (1995) Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report. J Am Acad Dermatol 33:422–642
Penello GA, Devesa S, Gail M (2000) Association of surface ultraviolet B radiation levels with melanoma and non-melanoma skin cancer in United States blacks. Cancer Epidemiol Biomarkers Prev 9:291–297
Penello GA, Devesa S, Gail M (1999) Using a mixed effects model to estimate geographic variation in cancer rates. Biometrics 55:774–781
Scotto J, Fears TR, Kraemer KH, Fraumeni JF (1996) Nonmelanoma skin cancer. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention, 2nd edn. Oxford University Press, New York, pp 1313–1330
Shapiro MP, Keen P, Cohen L (1953) Skin cancer in the South African Bantu. Br J Cancer 7:45–57
Oluwasanmi JO, Williams AO, Alli AF (1969) Superficial cancer in Nigeria. Br J Cancer 23:714–278
Crockett DJ (1962) Colour, cancer, and keloids in the Sudan. Br J Plast Surg 15:408–146
Singh B, Bhaya M, Shaha A, Har-El G, Lucente FE (1998) Presentation, course, and outcome of head and neck cancer in African Americans: a case control study. Laryngoscope 108:1159–1163
Abreo F, Sanusi D (1991) Basal cell carcinoma in North American blacks: clinical and histopathologic study of 26 patients. J Am Acad Dermatol 25:1005–1101
Altman A, Rosen T, Tschen JA, Hoffman T, Bruce S, Siegel DM et al (1987) Basal cell epithelioma in black patients. J Am Acad Dermatol 17:741–574
Kikuchi A, Shimizu H, Nishikawa T (1996) Clinical and histopathological characteristics of basal cell carcinoma in Japanese patients. Arch Dermatol 132:320–324
Hu S, Fangchao M, Collado-Mesa F, Kirsner RS (2004) UV radiation, latitude, and melanoma in US Hispanics and blacks. Arch Dermatol 140:819–824
Yohn JJ, Lupins MB, Norris DA (1982) Cultured melano-cytes from African American and white donors have different sunlight and ultraviolet A radiation sensitivities. J Invest Dermatol 99:454–459
Eide MJ, Weinstock MA (2005) Association of UV index, latitude, and melanoma incidence in non-white populations: US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001. Arch Dermatol 141:477–481
Fitzpatrick TB (1989) Enigma of the pathogenesis of primary melanoma: changing incidence and mortality in Japan and the United States. J Invest Dermatol 92:234–236
Amir H, Mbonde MP, Kitinya JN (1992) Cutaneous squamous cell carcinoma in Tanzania. Cent Afr J Med 38:439–443
Gray DT, Suman VJ, Su WP, Clay RP, Harmsen WS, Roenigk RK (1997) Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 133:735–740
Hoy WE (1996) Nonmelanoma skin cancer in Albuquerque, New Mexico. Cancer 77:2489–2495
Ishihara K, Saida T, Yamamato A (2001) Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol 6:109–116
Suzuki T, Ueda M, Naruse K, Nagano T, Harada S, Imaizumi K et al (1997) Incidence of actinic keratosis of Japanese in Kasai City, Hyogo. J Dermatol Sci 16:74–78
Nagano T, Ueda M, Suzuki T, Naruse K, Nakamura T, Taguchi M et al (1999) Skin cancer screening in Okinawa. Japan. J Dermatol Sci 19:161–165
Washington CV, Grimes PE (2003) Incidence and prevention of skin cancer. Cosmetic Dermatol 16:46–48
McCall CO, Chen SC (2002) Squamous cell carcinoma of the legs in African Americans. J Am Acad Dermatol 47:524–529
Mora RG, Perniciaro C, Lee B (1984) Cancer of the skin in blacks III: a review of nineteen black patients with Bowen 's disease. J Am Acad Dermatol 11:557–562
Yakubu A, Maboguaje OA (1995) Squamous cell carcinoma of the skin in Africans. Trop Geogr Med 47:91–93
Rippentrop JM, Joslyn SA, Konety BR (2004) Squamous cell carcinoma of the penis: evaluation of data from Surveillance, Epidemiology, and End Results program. Cancer 101:1357–6133
Schamroth JM, Weiss RM, Grieve TP (1987) Verrucous Bowen 's disease in an African American patient. S Afr Med J 71:527–852
Krishnan R, Lewis A, Orengo IF, Rosen T (2001) Pigmented Bowen 's disease (squamous cell carcinoma in-situ): a mimic of malignant melanoma. Dermatol Surg 27:673–674
Papageorgiou PP, Koumarianou AA, Chu AC (1998) Pigmented Bowen 's disease. Br J Dermatol 138:515–518
Rosen T, Tucker SB, Tschen J (1982) Bowen 's disease in African Americans. J Am Acad Dermatol 7:364–368
Sherman RN, Lee CW, Flynn KJ (1993) Cutaneous squamous cell carcinoma in African American patients with chronic discoid lupus erythematous. Int J Dermatol 32:677–679
Arrington JH III, Lockman DS (1979) Thermal keratoses and squamous cell carcinoma in situ associated with erythema ab igne. Arch Dermatol 115:1226–1228
Schwartz RA, Stoll HL Jr (1999) In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith CA, Karz SI et al (eds) Fitzpatrick 's dermatology in general medicine, 5th edn. McGraw-Hill, NewYork, pp 841–842
Keith WD, Kelly P, Sumrall AJ (1980) Squamous cell carcinoma arising in lesions of discoid lupus erythematosus in black persons. Arch Dermatol A6:315–317
Schoeman BJ (1996) Squamous cell carcinoma in neuropathic plantar ulcers in leprosy: another example of Marjolin 's ulcer. S Afr Med J 86:966–969
Rowe DE, Carroll RJ, Day CL (1992) Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol 26:976–990
Mora RG (1986) Surgical and aesthetic consideration of cancer of the skin in the black American. Am J Dermatol Surg Oncol 12:24–31
Nadiminti U, Rakkhit T, Washington C (2004) Morpheaform basal cell carcinoma in African Americans. Dermatol Surg 30:1550–2155
Lesher JL, D'Aubermont PCS, Brown VM (1988) Morpheaform basal cell carcinoma in a young black woman. J Dermatol Surg Oncol 14:200–203
Shreck R (1944) Cutaneous carcinoma IV: analysis of 20 cases in Negroes. Cancer Res 4:119–129
Munyao TM, Othieno-Abinya NA (1999) Cutaneous basal cell carcinoma in Kenya. East Afr Med J 76:97–100
Miller DL, Weinstock MA (1994) Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30:774–778
Tada M, Miki Y (1984) Malignant skin tumors among dermatology patients in university hospitals of Japan: a statistical survey, 1971–1975. J Dermatol 11:313–321
Schreiber MM, Shapiro SI, Berry CZ, Dahlen RF, Friedman RP (1971) The incidence of skin cancer in southern Arizona (Tucson). Arch Dermatol 104:124–127
Zhang B, Wang N, He W (1993) Clinicopathologic analysis of 60 cases of basal cell carcinoma. Chin Med Sci J 8:121–122
Buettner PG, Raasch BA (1998) Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 78:587–593
Wermoth BM, Fajordo LF (1970) Metastatic basal cell carcinoma: a review. Arch Pathol Lab Med 90:458–462
Howles JK (1936) Cancer of the skin in the Negro race. New Orleans Med Surg J 89:143–145
White JE, Strudwick WJ, Rickets WAN, Sampson C (1961) Cancer of the skin in Negroes: a review of 31 cases. JAMA 178:845–847
Davies JNP, Tank R, Meyer R, Thurston P (1968) Cancer of the integumentary tissues in Uganda Africans: the basis for prevention. J Natl Cancer Inst 41:31–51
Amonette RA, Kaplan RJ (1978) Squamous cell and basal cell carcinoma in black patients. J Dermatol Surg Oncol 2:158–611
Greenbaum SS, Krull EA, Simmons EB (1989) Basal cell carcinoma of the base of the penis in a black patient. J Am Acad Dermatol 20:317–319
Mora RG, Robins P (1978) Basal cell carcinomas in the center of the face: special diagnostic, prognostic, and therapeutic considerations. J Dermal Surg Oncol 4:315–320
Vitasa BC, Taylor HR, Strickland PT (1990) Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 65:2811–2817
Nguyen AV, Whitaker DE, Frodel J (1993) Differentiation of basal cell carcinoma. Otolaryngol Clin North Am 26:37–56
Walther RR, Grossman ME, Troy JL (1981) Basal cell carcinomas on the scalp of a black man many years after epilation by x-rays. J Dermatol Surg Oncol 7:570–571
Shore RE, Moseson M, Xue X, Tse Y, Harley N, Pasternack BS (2002) Skin cancer after x-ray treatment for scalp ringworm. Radiat Res 157:410–418
Parks J Y, Perry EL (1998) Microcystic adnexal carcinoma. Dermatol Surg 24:905–907
Higginson J, Oettle AJ (1960) Cancer incidence in the Banta and “Cape Colored” races of South America: report of a cancer survey in the Transvaal (1953e1955). J Natl Cancer Inst 24:589–671
Lanehart WH, Sanusi ID, Misra RP, O'Neal B (1983) Metastasizing basal cell carcinoma in a stasis ulcer in a black woman. Arch Dermatol 119:587–591
Haber RS, Beltrani VB, Yunakov MJ, Held JL (1989) Basal cell carcinoma of the scalp in a black patient. Cutis 44:59–60
Jacyk WK (1999) Xeroderma pigmentosum in black South Africans. Int J Dermatol 38:511–514
Lambert WC, Kaszica J, Chung H, Moore D (1984) Metastasizing basal cell carcinoma developing in a gunshot wound in a black man. J Surg Oncol 27:97–105
Ewing MR (1971) The significance of a single injury in the causation of basal cell carcinoma of the skin. Aust NZ J Surg 41:140–714
Matsuoka LY, Schauer PK, Sordillo PP (1981) Basal cell carcinoma in black patients. J Am Acad Dermatol 4:670–672
Woods SG (1995) Basal cell carcinoma in the black population. Int J Dermatol 34:517–518
Kidd MK, Tschen JA, Rosen T, Altman AR, Goldberg L (1989) Carcinoembryonic antigen in basal cell neoplasms in black patients: an immunohistochemical study. J Am Acad Dermatol 21:1007–1010
Xie J, Johnson RL, Zhang X, Bare JW, Waldman FM, Cogen PH et al (1997) Mutations of the patched gene in sporadic extracutaneous tumors. Cancer Res 57:2369–2372
Kulkarni P, Brashear R, Chuang TY (2003) Nevoid basal cell carcinoma syndrome in a person with dark skin. J Am Acad Dermatol 49:332–335
Martin S, Waisman M (1978) Basal cell nevus syndrome in a black patient: report of a case and review of the literature. Arch Dermatol 114:1356–1357
Gorlin RJ (1995) Genodermatoses with malignant potential: nevoid basal cell carcinoma syndrome. Dermatol Clin 13:113–125
Hinkley GW, Rauschkolb RR (1962) Basal cell epithelioma metastasizing to lymph nodes. Arch Dermatol 86:332–335
Oram Y, Orengo I, Alford E, Green LK, Rosen T, Netscher DT (1994) Basal cell carcinoma of the scalp resulting in spine metastasis in a black patient. J Am Acad Dermatol 31:916–920
Schwartz RA, DeJager RL, Janniger CK, Lamber WC (1986) Giant basal cell carcinoma with metastases and myelophthisic anemia. J Surg Oncol 33:223–226
Troyanova P, Danon S, Ivanova T (2002) Nonmelanoma skin cancer and risk of subsequent malignancies: a cancer registry based study in Bulgaria. Neoplasma 49:81–85
Frisch M, Melbye M (1995) New primary cancers after squamous cell skin cancer. Am J Epidemiol 41:916–922
Rosenberg CA, Greenland P, Khandekar J, Loar A, Ascensao J, Lopez AM (2004) Association of nonmelanoma skin cancer with second malignancy. Cancer 100:130–138
Norval M (2001) Effects of solar irradiation on the human immune system. In: Giacomoni PU (ed) Sun protection in man. Elsevier, Amsterdam, pp 91–113
Stab F, Hoppe U, Sauermann G (1994) Urocanic acid and its function in endogenous antioxidant defense and UV-protection in human skin (abstract). J Invest Dermatol 102:666
Beckstein MS, Windle BH (1996) Basal cell carcinoma in the groin of a black patient with femoral vessel invasion and a second primary malignancy. Plast Reconstr Surg 98:872–875
Burns JE, Eisenhauer ED, Jabaley ME, Cruse JM (1980) Cellular immune deficiency in black patients with basal cell carcinoma. J Surg Oncol 13:129–134
Bigler C, Feldman J, Hall E, Padilla RS (1996) Pigmented basal cell carcinoma in Hispanics. J Am Acad Dermatol 34:751–752
Kalter DC, Goldberg LH, Rosen T (1984) Darkly pig-mented lesions in dark-skinned patients. J Dermatol Surg Oncol 10:876–881
Roenigk RK, Ratz JL, Bailin PL, Wheeland RG (1986) Trends in the presentation and treatment of basal cell carcinoma. J Dermatol Surg Oncol 12:860–865
Miller SJ (1991) Biology of basal cell carcinoma (part I). J Am Acad Dermatol 24:1–13
Preston DS, Stern RS (1992) Nonmelanoma cancers of the skin. N Engl J Med 327:1649–1662
Emmett AJJ (1990) Surgical analysis and biologic behavior of 2277 basal cell carcinomas. Aust NZ J Surg 60:855–863
Mora RG, Lee B (1984) Cancer of the skin in blacks I V. a review of nineteen black patients with Kaposi 's sarcoma. J Am Acad Dermatol 11:563–567
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi 's sarcoma. Science 266:1865–9186
Glocker-Reis LA, Miller BA, Hankey BF (1994) SEER cancer statistics review, 1973–1991. National Cancer Institute, Bethesda, MD. National Institutes of Health Publication 94
Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoore A et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10–30
Cress RD, Holly EA (1997) Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California Cancer Registry data, 1988–1993. Cancer Causes Control 8:246–522
Giraud RM, Rippey E, Rippey JJ (1975) Malignant melanoma of the skin in black Africans. S Afr Med J 49:665–668
American Cancer Society (2003) Cancer facts and figures. American Cancer Society, Atlanta, pp 1–52
Swan MC, Hudson DA (2003) Malignant melanoma in South Africans of mixed ancestry: a retrospective analysis. Melanoma Res 13:415–419
Elder DE (1995) Skin cancer: melanoma and other specific nonmelanoma skin cancers. Cancer 75:245–256
Hudson DA, Krige JE (1995) Melanoma in black South Africans. J Am Coll Surg 180:65–71
Vazquez-Botet M, Latoni D, Sanchez JL (1990) Malignant melanoma in Puerto Rico. Biol Assoc Med P R 82:454–457
Chen YJ, Wu CY, Chen JT, Shen JL, Chen CC, Wang HC (1999) Clinicopathologic analysis of malignant melanoma in Taiwan. J Am Acad Dermatol 41:945–949
Bellows CF, Belafsky P, Fortgang IS, Beech DJ (2001) Melanoma in African-Americans: trends in biological behavior and clinical characteristics over two decades. J Surg Oncol 78:10–16
Miller RW, Rabkin CS (1999) Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 8:153–158
Taylor SC (2002) Skin of color: biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol 3:541–562
Bergfelt L, Newell GR, Sider JG, Kripke ML (1989) Incidence and anatomic distribution of cutaneous melanoma among United States Hispanics. J Surg Oncol 40:222–226
Kosary C, Ries L, Miller B (1995) SEER cancer statistics review, 1973–1992: tables and graphs. National Cancer Institute, Bethesda, MD
Surveillance, Epidemiology, and End Results (SEER) Program (http://seer.cancer.gov) (2005) Public-Use Data Fast Stats (1992–2001) [Database on CD-ROM]. Bethesda (MD): National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; based on the November 2003 submission. Accessed 1 April 2005
Garsaud P, Boisseau-Garsaud AM, Ossundo M, Azaloux H, Escarmant P, Mab GL et al (1998) Epidemiology of melanoma in the French West Indies (Martinique), 1998. Am J Epidemiol 147:66–68
Black WC, Goldhahn RT, Wiggins C (1987) Melanoma within a southwestern Hispanic population. Arch Dermatol 123:1331–4133
Pathak DR, Samet JM, Howard CA, Key CR (1982) Malignant melanoma of the skin in New Mexico 1969–1977. Cancer 50:1440–1446
Trapido EJ, Burciaga-Valdez R, Obeso JL, Strickman-Stein N, Rotger A, Perez-Stable EJ (1995) Epidemiology of cancer among Hispanics in the United States. J Natl Cancer Inst Monogr 18:17–28
Rhodes AR, Weinstock MA, Fitzpatrick TB, Mihm MC Jr, Sober AJ (1987) Risk factors for cutaneous melanoma: a practical method of recognizing predisposed individuals. JAMA 258:3146–3154
Waterhouse J, Correa P, Muir C, Powel J (eds) (1976) Cancer incidence in five continents, vol. 4. International Agency for Research in Cancer, Lyon
Tanaka N, Amagasa T, Iwaki H (1994) Oral malignant melanoma in Japan. Oral Surg Oral Med Oral Pathol 78:81–90
Swerdlow AJ (1990) International trends in cutaneous melanoma. In: Davis DL, Hoel D (eds) Trends in cancer mortality in industrial countries, vol 609. New York Academy of Sciences, New York, pp 235–251
Stern RS (1999) The mysteries of geographic variability in non-melanoma skin cancer incidence. Arch Dermatol 135:843–484
Krishnamurthy S, Yeole B, Joshi S, Gujarathi M, Jussawalla DJ (1994) The descriptive epidemiology and trends in incidence of non-ocular malignant melanoma in Bombay and India. Indian J Cancer 31:64–71
Reintgen DS, McCarty KM, Cox E, Seigler HF (1982) Malignant melanoma in black American and white American populations: a comparative review. JAMA 248:1856–1859
Krementz ET, Sutherland CM, Carter RD (1976) Malignant melanoma in the American black. Ann Surg 5:533–542
Ishihara K, Ikeda S, Arao T, Mori S, Ohura T, Takahashi M et al (1989) Prognostic factors for malignant melanoma in Japanese. Skin Cancer 4:349–360
Holly E, Ashton D, Ahn D, Kristiansen J (1995) Cutaneous melanoma in women: exposure to sunlight, ability to tan, and other UV related risk factors. Am J Epidemiol 141:923–933
Whiteman DC, Whiteman CA, Green AC (2001) Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 12:69–82
Elwood JM (1996) Melanoma and sun exposure. Semin Oncol 23:650–666
Coleman WP, Gately LE, Krementz AB (1980) Nevi, lentigi-nes, and melanoma in blacks. Arch Dermatol 116:548–551
McCredie M, Coates MS, Ford JM (1990) Cancer incidence in migrants to New South Wales from England, Wales, Scotland and Ireland. Br J Cancer 62:3992–3996
Cooke KR, Fraser J (1985) Migration and death from malignant melanoma. Int J Cancer 36:175–817
Titus-Ernstoff L (2000) An overview of the epidemiology of cutaneous melanoma. Clin Plast Surg 27:305–316
Byrd KM, Wilson DC, Hoyler SS (2004) Advanced presentation of melanoma in African Americans. J Am Acad Dermatol 50:142–143
Muchmore JH, Mizuguchi RS, Lee C (1996) Malignant melanoma in American black females: an unusual distribution of primary sites. J Am Coll Surg 183:457–465
Collins RJ (1984) Melanoma in the Chinese of Hong Kong: emphasis on volar and subungual sites. Cancer 54:1482–8148
Seiji M, Takahashi M (1982) Acral melanoma in Japan. Hum Pathol 13:607–609
Hinds MW (1979) Anatomic distribution of malignant melanoma of the skin among non-Caucasians in Hawaii. Br J Cancer 40:497–499
Pantangeo EE, Canlas M, Basa G, Sin R (1963) Observations in the incidence, biology, and pathology of skin cancer among Filipinos. Natl Cancer Inst Monogr 10:109–125
Pringgoutomomo S (1963) Skin cancer in Indonesia. Natl Cancer Inst Monogr 10:191–195
Johnson DS, Yamane S, Morita S, Yonehara C, Wong J (2003) Malignant melanoma in non-Caucasians: experience from Hawaii. Surg Clin N Am 83:275–282
O'Leary JA, Berend KR, Johnson JL, Levin LS, Seigler HF (2000) Subungual melanoma. Clin Orthop Relat Res 378:206–122
Pantoja E, Llobet RE, Roswit B (1976) Melanomas of the lower extremity among native Puerto Ricans. Cancer 38:1420–3142
Black WC, Palmer C, Varsa E, Bartow JA, Fovcar E, Burgdorf WH (1987) The New Mexico Melanoma Registry: a model of a statewide cooperative program. Am J Dermatopathol 9:10–14
Rahman Z, Taylor SC (2001) Malignant melanoma in African Americans. Cutis 67:403–406
Hudson DA, Krige JE, Stubbings H (1998) Plantar melanoma: results of treatment in three population groups. Surgery 124:877–882
Pitche P, Napo-Koura G, Kpodzro K, Tchangai-Wall K (1996) Melanoma in Togo: a retrospective study over 20 years. Ann Dermatol Venereol 123:786–788
Vayer A, Lefor AT (1993) Cutaneous melanoma in African Americans. South Med J 86:181–182
Rippey JJ, Rippey E (1984) Epidemiology of malignant melanoma of the skin in South Africa. S Afr Med J 65:595–598
Kukita A, Ishihara K (1989) Clinical features and distribution of malignant melanoma and pigmented nevi on the soles of the feet in Japan. J Invest Dermatol 92:2105–2135
Kato T, Suetake T, Tabata N (1999) Epidemiology and prognosis of plantar melanoma in 62 Japanese patients over a 28 year period. Int J Cancer 38:515–519
Feun LG, Raub WA Jr, Duncan RC (1994) Melanoma in a southeastern Hispanic population. Cancer Detect Prev 18:145–512
Stevens NG, Liff JM, Weiss NS (1990) Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Int J Cancer 45:691–369
Coleman WP, Loria PR, Reed RJ, Krementz ET (1980) Acral lentiginous melanoma. Arch Dermatol 116:773–677
Wong TY, Ohara K, Kawashima M, Sober AJ, Nogita T, Mihm MC Jr (1996) Acral lentiginous melanoma (including in-situ melanoma) arising in association with naevocel-lular naevi. Melanoma Res 6:241–246
Slingluff CL, Vollmer R, Seigler HF (1990) Acral melanoma: a review of 185 patients with identification of prognostic variables. J Surg Oncol 45:91–98
Sutherland CM, Mather FJ, Muchmore JH, Carter RD, Reed RJ, Krementz ET (1993) Acral lentiginous melanoma. Am J Surg 166:64–67
Patterson RH, Helwig EB (1980) Subungual melanoma: a clinicopathologic study of 125 primary cutaneous melanomas. Cancer 46:2492–2540
Feibleman CE, Stoll M, Maize JC (1980) Melanomas of the palm, sole, and nail bed: a clinicopathologic study. Cancer 46:2492–5204
Gloster HM Jr (1996) Dermatofibrosarcoma protuberans. J Am Acad Dermatol 35:355–374
Garg SK, Subbuswamy SG, Alabi JO, Lawrie JH (1978) Der-matofibrosarcoma protuberans in northern Algeria: a clinico-pathological review of 17 cases. Clin Oncol 4:113–122
Dupree WB, Langloss JM, Weiss SW (1985) Pigmented dermatofibrosarcoma protuberans (Bednar tumor): a pathologic, ultrastructural, and immunohistochemical study. Am J Surg Pathol 9:630–639
DiGiovanna JJ, Safai B (1981) Kaposi 's sarcoma: retrospective study of 90 cases with particular emphasis on the familial occurrence, ethnic background and prevalence of other diseases. Am J Med 71:779–783
Laor Y, Schwartz RA (1979) Epidemiologic aspects of American Kaposi 's sarcoma. J Surg Oncol 12:299–303
Isaacson C (1979) Cancer of the skin in urban blacks of South Africa. Br J Dermatol 100:347–350
Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ (2002) Cancer surveillance series: trends in Kaposi 's sarcoma and non-Hodgkin 's lymphoma incidence in the United States from 1973–1998. J Natl Cancer Inst 16:1204–1210
Lennette ET, Blackbourn DJ, Levy JA (1996) Antibodies to human herpes virus type 8 in the general population and in Kaposi 's sarcoma patients. Lancet 348:858–861
Greenblatt RM, Jacobson L P, Levine AM, Melnick S, Anastos K, Cohen M et al (2001) Human herpes virus 8 infection and Kaposi 's sarcoma among human immunodeficiency virus-infected and uninfected women. J Infect Dis 183:1130–1134
Akaraphanth R, Douglass MC, Lim HW (2000) Hypopigmented mycosis fungoides: treatment and a 6½ year follow-up of 9 patients. J Am Acad Dermatol 42:33–39
Weinstock MA, Horm JW (1988) Mycosis fungoides in the United States: increasing incidence and descriptive epidemiology. JAMA 260:42–46
Weinstock MA, Gardstein B (1999) Twenty-year trends in the reported Incidence of mycosis fungoides and associated mortality. Am J Public Health 89(8):1240–4
Stone MC, Styles AR, Cockerell CJ (2001) Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature. Cutis 67:133–138
Lambroza E, Cohen SR, Phelps R, Lebwohl M, Braverman IM, Dicostanzo D (1995) Hypopigmented variant of mycosis fungoides: demography, histopathology, and treatment of seven cases. J Am Acad Dermatol 32:987–993
Whitmore SE, Simmons-O'Brien E, Rotter FS (1994) Hypopigmented mycosis fungoides. Arch Dermatol 130:476–480
Braverman IM (1991) Cutaneous T-cell lymphoma. Curr Probl Dermatol 3:184–227
Dekio S, Funaki M, Jidoi J, Mihara M (1994) Trichilemmal carcinoma on the thigh: report of a case. J Dermatol 21:494–649
Laochumroonvorapong P, Kokta V, Quan MB (2002) Trichilemmal carcinoma in an African American. Dermatol Surg 28:284–628
Anderson LL, Phipps TJ, McCollough ML (1992) Neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in a black. J Dermatol Surg Oncol 18:375–380
Simstein NL, Soluggs NK (1998) Merkel cell tumor: two cases. Int Surg 83:60–62
Ohtsuka H, Nagamatsu S (2002) Microcystic adnexal carcinoma: review of 51 Japanese patients. Dermatology 204:190–193
Peterson CM, Ratz JL, Sangueza OP (2001) Microcystic adnexal carcinoma: first reported case in an African American man. J Am Acad Dermatol 45:283–285
Author information
Authors and Affiliations
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ulrich, M. et al. (2010). Skin Cancer Under Special Circumstances. In: Stockfleth, E., Rosen, T., Shumack, S. (eds) Managing Skin Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79347-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-540-79347-2_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79346-5
Online ISBN: 978-3-540-79347-2
eBook Packages: MedicineMedicine (R0)